Success Metrics

Clinical Success Rate
91.7%

Based on 11 completed trials

Completion Rate
92%(11/12)
Active Trials
1(7%)
Results Posted
18%(2 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_2
1
7%
Ph not_applicable
3
20%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

1

trials recruiting

Total Trials

15

all time

Status Distribution
Active(1)
Completed(11)
Terminated(2)
Other(1)

Detailed Status

Completed11
unknown1
Recruiting1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
1
Success Rate
91.7%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (25.0%)
N/A3 (75.0%)

Trials by Status

unknown17%
recruiting17%
completed1173%
terminated17%
withdrawn17%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials

All 15 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
15